Self-reported cognitive concerns and abilities: Two sides of one coin?

Psycho-Oncology

Volumn 23, Issue 10, 2014, Pages 1133-1141

  Lai, Jin Shei ^a   Wagner, Lynne I ^a   Jacobsen, Paul B ^b   Cella, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; COGNITION; COGNITIVE ABILITY; COGNITIVE CONCERN; EDUCATIONAL STATUS; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY; QUALITY OF LIFE; SELF REPORT; SEX DIFFERENCE; AGED; DAILY LIFE ACTIVITY; FACTOR ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; QUESTIONNAIRE; REPRODUCIBILITY; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COGNITION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF REPORT; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84907931238     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3522     Document Type: Article

References (62)

1. American cancer society: cancer facts & figs. 2012. Oncol Nutr Connect 2012;20(4):18-19.
2. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer 2005;104(S11):2565-2576.
3. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012;30(30):3675-3686.
4. Ganz PA. Doctor, will the treatment you are recommending cause chemobrain? J Clin Oncol 2012;30(3):229-231.
5. Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012;30(3):274-281.
6. Silverman D, Dy C, Castellon S, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 2007;103(3):303-311.
7. Jim HSL, Phillips KM, Chait S, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012;30(29):3578-3587.
8. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 2012;38(7):926-934.
9. Reid-Arndt S, Cox C. Stress, coping and cognitive deficits in women after surgery for breast cancer. J Clin Psychol Med Settings 2012;19:1-11.
10. Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv Res Pract 2009;3(4):223-232.
11. Tannock IF, Ahles TA, Ganz PA, van Dam F. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004;22(11):2233-2239.
12. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004;26(7):955-969.
13. Pullens MJJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 2010;19(11):1127-1138.
14. Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology 2008;17(12):1189-1195.
15. Jenkins V, Shilling V, Deutsch G, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94(6):828-834.
16. Hermelink K, Untch M, Lux MP, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007;109(9):1905-1913.
17. Hurria A, Goldfarb S, Rosen C, et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 2006;98(3):343-348.
18. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 2009;116(1):129-130.
19. Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 2012;30(10):1080-1086.
20. Ganz PA, Bower JE, Kwan L, et al. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun 2013;30:S99-S108.
21. Lai J-S, Zelko F, Krull K, et al. Parent-reported cognition of children with cancer and its potential clinical usefulness. Qual Life Res, Epub ahead of print 2013:1-10.
22. Jacobs SR, Jacobsen PB, Booth-Jones M, Wagner LI, Anasetti C. Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients. J Pain Symptom Manage 2007;33(1):13-23.
23. Fliessbach K, Helmstaedter C, Urbach H, et al. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 2005;64(7):1184-1188.
24. Skaali T, Fossa˚ SD, Andersson S, et al. Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. J Psychosom Res 2011;70(5):403-410.
25. Schagen SB, Boogerd W, Muller MJ, et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta oncologica (Stockholm, Sweden) 2008;47(1):63-70.
26. Poppelreuter M, Weis J, Külz AK, Tucha O, Lange KW, Bartsch HH. Cognitive dysfunction and subjective complaints of cancer patients: a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 2004;40(1):43-49.
27. Hermelink K, Küchenhoff H, Untch M, et al. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psycho-Oncology 2010;19(12):1321-1328.
28. Costa PT, Jr., McCrae RR. Neuroticism, somatic complaints, and disease: is the bark worse than the bite? J Pers 1987;55(2):299-316.
29. Mora PA, Halm E, Leventhal H, Ceric F. Elucidating the relationship between negative affectivity and symptoms: the role of illness-specific affective responses. Ann Behav Med Publ Soc Behav Med 2007;34(1):77-86.
30. Lai JS, Butt Z, Wagner L, et al. Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage 2009;37(6):982-995.
31. Lai JS, Garcia SF, Salsman JM, Rosenbloom S, Cella D. The psychosocial impact of cancer: evidence in support of independent general positive and negative components. Qual Life Res 2012;21(2):195-207.
32. Wagner LI, Sweet J, Butt Z, Lai JS, Cella D. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 2009;7:W32-W39.
33. Lai J-S, Butt Z, Zelko F, et al. Development of a parent-report cognitive function item bank using item response theory and exploration of its clinical utility in computerized adaptive testing. J Pediatr Psychol 2011;36(7):766-779.
34. Lai JS, Cella D, Choi SW, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil 2011;92(10 Supplement):S20-S27.
35. Cella D, Gershon R, Lai JS, Choi S. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res 2007;16 (Suppl 1):133-141.
36. Hays RD, Liu H, Spritzer K, Cella D. Item response theory analyses of physical functioning items in the medical outcomes study. Med Care 2007;45(5 Suppl 1):S32-S38.
37. Lai JS, Cella D, Dineen K, Von Roenn J, Gershon R. An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol 2005;58(2):190-197.
38. Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW. Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res 2003;12(5):485-501.
39. Gershon R, Cella D, Dineen K, Rosenbloom S, Peterman A, Lai JS. Item response theory and health-related quality of life in cancer. Expert Rev Pharmacoecon Outcomes Res 2003;3(6):783-791.
40. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 1999;6(1):1-55.
41. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 2007;45(5 Suppl 1):S22-S31.
42. Muthen LK, Muthen BO. Mplus User's Guide. Muthen & Muthen: Los Angeles, CA, 2006.
43. Lai JS, Crane PK, Cella D. Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue. Qual Life Res 2006;15(7):1179-1190.
44. McDonald RP. Test Theory: A Unified Treatment. Lawrence Earlbaum Associates, Inc.: Mahwah, NJ, 1999.
45. Reckase MD. The past and future of multidimensional item response theory. Appl Psychol Meas 1997;21:25-36.
46. Reise SP, Morizot J, Hays RD. The role of the bi-factor model in resolving dimensionality issues in health outcomes measures. Qual Life Res 2007;16(Suppl 1):19-31.
47. Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometrika Monograph, No. 17, 1969.
48. Samejima F. Graded response model, van der Linden WJ, Hambleton RK (eds.), In Handbook of Modern Item Response Theory Spinger: New York, 1997; 85-100
49. Folk VG, Green BF. Adaptive estimation when the unidimensionality assumption of IRT is violated. Appl Psychol Meas 1989;13(4):373-389.
50. Gibbons RD, Immekus JC, Bock RD The Added Value of Multidimensional IRT Models: Didactic Workbook. Center for Health Statistics, University of Illinois at Chicago: Chicago, IL, 2007.
51. Reise SP, Cook KF, Moore TM. A direct modeling approach for evaluating the impact of multidimensionality on unidimensional item response theory model parameters. Reise SP, Revicki D (eds.), In Handbook of Applied Item Response Theory in Typical Performance Assessment. Taylor & Francis: New York, 2013.
52. Gibbons R, Hedeker D. Full-information item bi-factor analysis. Psychometrika 1992;57(3):423-436.
53. Gibbons RD, Bock RD, Hedeker D, et al. Full-information item bi-factor analysis of graded response data. Appl Psychol Meas 2007;31(1):4-19.
54. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European organization for research and treatment of cancer approach to developing questionnaire modules: an update and overview. EORTC Qual Life Study Group Qual Life Res 1998;7(4):291-300.
55. Rosler A, Gonnenwein C, Muller N, Sterzer P, Kleinschmidt A, Frolich L. The fuzzy frontier between subjective memory complaints and early dementia: a survey of patient management in German memory clinics. Dement Geriatr Cogn Disord 2004;17(3):222-230.
56. Saykin AJ, Wishart HA, Rabin LA, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006;67(5):834-842.
57. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 2007;25(25):3866-3870.
58. Joly F, Rigal O, Noal S, Giffard B. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psycho-Oncology 2011;20(12):1251-1258.
59. Hess L, Insel K. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 2007;34(5):981-994.
60. Raffa RB. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemobrain'. J Clin Pharm Ther 2010;35(1):1-9.
61. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology 2001;56(11):1539-1545.
62. Mahone EM, Martin R, Kates WR, Hay T, Horska A. Neuroimaging correlates of parent ratings of working memory in typically developing children. J Int Neuropsychol Soc 2009;15(1):31-41.